Drug Information

Drug General Information
Drug ID
D02SUR
Former ID
DNC000855
Drug Name
L-697,661
Drug Type
Small molecular drug
Indication Human immunodeficiency virus infection [ICD9: 279.3; ICD10:B20-B26] Phase 2 [533696]
Structure
Download
2D MOL

3D MOL
Formula
C16H15Cl2N3O2
Canonical SMILES
CCC1=C(NC(=O)C(=C1)NCC2=NC3=C(C=CC(=C3O2)Cl)Cl)C
InChI
1S/C16H15Cl2N3O2/c1-3-9-6-12(16(22)20-8(9)2)19-7-13-21-14-10(17)4-5-11(18)15(14)23-13/h4-6,19H,3,7H2,1-2H3,(H,20,22)
InChIKey
WHFRDXVXYMGAJD-UHFFFAOYSA-N
CAS Number
CAS 73090-70-7
PubChem Compound ID
65002
PubChem Substance ID
598478, 8031189, 8189439, 12014636, 14900904, 43121853, 50070498, 50071138, 50168735, 103167681, 103855635, 103948987, 104332615, 117584479, 125691917, 129581310, 134340164, 134348701, 135143410, 137089827, 162389151, 163303949, 163515607, 226902408
SuperDrug ATC ID
J04BA02
SuperDrug CAS ID
cas=000080080
Target and Pathway
Target(s) HIV reverse transcriptase Target Info Modulator
References
Ref 533696A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med. 1993 Oct 7;329(15):1065-72.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.